Neurology Minute podcast

A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease

0:00
2:02
Rewind 15 seconds
Fast Forward 15 seconds

Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.

Show citation: 

Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026;25(3):268-278. doi:10.1016/S1474-4422(25)00483-1 

More episodes from "Neurology Minute"